UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

Nature communications, 2020-10, Vol.11 (1), p.1-13, Article 4982

2020

Volltextzugriff (PDF)

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis

Journal of gastroenterology, 2020-03, Vol.55 (3), p.330-341

2020

Volltextzugriff (PDF)

Maternal dyslipidemia and altered cholesterol metabolism in early pregnancy as a risk factor for small for gestational age neonates

Scientific reports, 2021-10, Vol.11 (1), p.21066-21066, Article 21066

2021

Volltextzugriff (PDF)

Interaction between sarcopenia and nonalcoholic fatty liver disease

Clinical and molecular hepatology, 2023-02, Vol.29 (Suppl), p.S68-S78

2023

Volltextzugriff (PDF)

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

Journal of hepatology, 2017-01, Vol.66 (1), p.123-131

2017

Volltextzugriff (PDF)

Additive effects of PNPLA3 and TM6SF2 on the histological severity of non‐alcoholic fatty liver disease

Journal of gastroenterology and hepatology, 2018-06, Vol.33 (6), p.1277-1285

2018

Volltextzugriff (PDF)

Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease

PloS one, 2017-11, Vol.12 (11), p.e0188321

2017

Volltextzugriff (PDF)

Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease

Hepatology international, 2020-12, Vol.14 (6), p.1048-1056

2020

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight

PloS one, 2019-08, Vol.14 (8), p.e0221400-e0221400

2019

Volltextzugriff (PDF)

Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis

Gut microbes, 2022-12, Vol.14 (1), p.2078612

2022

Volltextzugriff (PDF)

Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease

Liver international, 2018-02, Vol.38 (2), p.331-341

2018

Volltextzugriff (PDF)

It's Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging

Gut and Liver, 2019, 13(1), , pp.5-6

2019

Volltextzugriff (PDF)

Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease

Hepatology international, 2020-09, Vol.14 (5), p.798-807

2020

Volltextzugriff (PDF)

The risk of pregnancy‐associated hypertension in women with nonalcoholic fatty liver disease

Liver international, 2020-10, Vol.40 (10), p.2417-2426

2020

Volltextzugriff (PDF)

Development of early prediction model for pregnancy-associated hypertension with graph-based semi-supervised learning

Scientific reports, 2022-09, Vol.12 (1), p.15793-13, Article 15793

2022

Volltextzugriff (PDF)

Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study

Hepatology international, 2023-04, Vol.17 (2), p.367-376

2023

Volltextzugriff (PDF)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Liver cancer (Basel ), 2024-08, Vol.13 (4), p.426-437

2024

Volltextzugriff (PDF)

Efficacy and Safety of Pregabalin for Muscle Cramps in Liver Cirrhosis: A Double-Blind Randomized Controlled Trial

Journal of Korean Medical Science, 2022, 37(7), , pp.1-16

2022

Volltextzugriff (PDF)

Correction: Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight

PloS one, 2019-10, Vol.14 (10), p.e0224845-e0224845

2019

Volltextzugriff (PDF)

Correction: Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease

PloS one, 2018-06, Vol.13 (6), p.e0200055-e0200055

2018

Volltextzugriff (PDF)

Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease

Computational and structural biotechnology journal, 2021-01, Vol.19, p.5920-5930

2021

Volltextzugriff (PDF)

Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study

Diagnostic pathology, 2018-04, Vol.13 (1), p.23-23, Article 23

2018

Volltextzugriff (PDF)

Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease

Hepatology international, 2020-03, Vol.14 (2), p.270-280

2020

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women

PloS one, 2017-08, Vol.12 (8), p.e0182708-e0182708

2017

Volltextzugriff (PDF)

Clinical and Endoscopic Features of Colonic Anisakiasis in Korea

Korean journal of parasitology, 2019-08, Vol.57 (4), p.411-417

2019

Volltextzugriff (PDF)

1 – 25 von 265

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(234)
Mit Volltextzugriff
(235)

Publikationsform

Artikel
(264)
Tagungsberichte
(1)

Sprache

Englisch
(219)
Koreanisch
(46)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis

Maternal dyslipidemia and altered cholesterol metabolism in early pregnancy as a risk factor for small for gestational age neonates

Interaction between sarcopenia and nonalcoholic fatty liver disease

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

Additive effects of PNPLA3 and TM6SF2 on the histological severity of non‐alcoholic fatty liver disease

Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease

Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight

Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis

Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease

It's Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging

Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease

The risk of pregnancy‐associated hypertension in women with nonalcoholic fatty liver disease

Development of early prediction model for pregnancy-associated hypertension with graph-based semi-supervised learning

Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study

Efficacy and Safety of Pregabalin for Muscle Cramps in Liver Cirrhosis: A Double-Blind Randomized Controlled Trial

Correction: Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight

Correction: Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease

Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease

Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study

Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease

Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women

Clinical and Endoscopic Features of Colonic Anisakiasis in Korea

Suchergebnisse filtern